# FDA recall D-0727-2022

> **Taro Pharmaceuticals U.S.A., Inc.** · Class III · drug recall initiated 2022-02-25.

## Product

Clotrimazole and Betamethasone Dipropionate Cream USP, 1%/0.05%,15 g tubes, Rx only, Manufactured by: Taro Pharmaceuticals Industries Ltd. Haifa Bay, Israel 2624761, Distributed by: Taro Pharmaceuticals U.S.A., Inc.  Hawthorne, NY 10532, NDC 51672-4048-1

## Reason for recall

Failed Content Uniformity Specifications: Out-of-specification result for the Betamethasone Dipropionate assay of a stability sample

## Distribution

Product was distributed to one retail consignee in NY.

## Key facts

- **Recall number:** D-0727-2022
- **Recalling firm:** Taro Pharmaceuticals U.S.A., Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-02-25
- **Report date:** 2022-04-06
- **Termination date:** 2024-09-09

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Hawthorne, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0727-2022

## Citation

> AI Analytics. FDA recall D-0727-2022. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0727-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*